Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The FDA approved two fruit-flavored vape lines from a Los Angeles company, a notable policy reversal that comes as po...
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...
A crypto veteran nicknamed the 'godfather crypto' argues Bitcoin could reach $1 million in time, yet warns that a nea...
Analysts on Thursday issued fresh calls across a raft of names, from Commercial Metals to Wix.com, signaling continue...
AI-driven storage demand is lifting pricing power for Seagate and Western Digital, reshaping margins and investor sen...
The Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
The U.S. housing agency released a deregulation roadmap aimed at trimming permit fees, simplifying building codes, an...
HP's sustainability chief outlines a practical, customer-focused 2026 plan, framed as a year life what matters moment...
Grok AI signals a measured Bitcoin advance through June 2026, forecasting a target around the mid-80Ks. The model cit...
AI-driven models are outlining a bold bitcoin price prediction: reach $1 million for BTC by 2035, supported by ETF in...
Aging Americans and their families increasingly rely on robot-assisted home care as workers for in-home support grow ...